SANTIAGO, Chile (AP) — Chile has become the first country in Latin America to sell cannabis-based medicines at pharmacies.
The pilot program was launched Wednesday at two pharmacies in the Chilean capital, which will sell the T100 and TC100 chronic pain-relief medicines made in Canada.
The program is financed by an alliance between Chile’s Alef Biotechnology and Canada’s Tilray under the supervision of the Chilean National Health institute.
Alef Biotechnology President Roberto Roizman says the viability of the program will be evaluated in six months to determine if it can be produced in Chile and exported.
Tilray is a pioneer in the research, production and distribution of cannabis-based medicines.
Chile has been joining an international trend of easing restrictions on marijuana for medical or personal use.
Canada Estimates $1 Billion in Legal Cannabis Sales in First Three Months
New Zealand City Has 10 Synthetic Cannabis Overdoses in 48 Hours
Billboards Urge Utah to Vote for Medical Marijuana by Quoting Mormon Scripture
Governor of the Commonwealth of the Northern Mariana Islands Legalizes Cannabis
Culture6 days ago
First Ever Trial to Study the Effects of Microdosing LSD Began This Month
CBD7 days ago
Coca-Cola in Talks to Make the Next CBD-Infused Beverage
Health7 days ago
Adderall and Weed: Learn More About the Combo
Guides5 days ago
What Do The Colors of Marijuana Mean?
Health6 days ago
Tobacco vs. Weed: The Differences, Pros, and Cons
Medical Marijuana5 days ago
Canadian Cannabis Company Tilray to Export Products to United States
News6 days ago
South African Court Rules Private, Adult-Use Cannabis is Legal
Health6 days ago
Study Finds Lesbian, Gay, Bisexual Youth More Likely to Use Multiple Substances